VCM
BIO icon

Voleon Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Voleon Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,000
Closed -$2.59M – 26
2019
Q4 		$2.59M Sell
7,000
-3,000
-30% -$1.06M 0.15% 94
2019
Q3 		$3.33M Buy
+10,000
New +$3.26M 0.26% 71

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Voleon Capital Management's BIO Position: Q1 2020 in Review

Voleon Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2020, closing a stake of 7,000 shares — an estimated $2.59M sold.

Voleon Capital Management first reported a position in BIO in Q3 2019 and held it in 2 quarters. The position peaked at $3.33M in Q3 2019. 406 funds tracked by Wall St. Rank hold BIO as of Q1 2020.

  • Voleon Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2020 after selling out during the quarter.
  • Voleon Capital Management sold 7,000 Bio-Rad Laboratories Class A shares in Q1 2020, an estimated $2.59M.
  • Voleon Capital Management first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and held it in 2 quarters.
  • Voleon Capital Management's Bio-Rad Laboratories Class A position peaked at $3.33M in Q3 2019.
  • 406 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2020.

Based on Voleon Capital Management's 13F filing for Q1 2020.